Associations of plasma Neurofilament light chain with sarcopenia and physical capacity in patients with Alzheimer’s diseases
Acta Neurologica Belgica · 2025
DOI: 10.1007/s13760-025-02759-2 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Acta Neurologica Belgica, 2025. Verfasst von Rizwan Qaisar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Medical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates. rqaisar@sharjah.ac.ae. Hauptthemen laut MEDLINE: Sarcopenia, Alzheimer Disease, Neurofilament Proteins. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: University of Sharjah.
Themen: Demenz
Abstract (Originalsprache)
BACKGROUND: Despite the close association of Alzheimer's disease (AD) with muscle decline, the biomarkers of age-related muscle loss, termed sarcopenia, in AD remain elusive. OBJECTIVES: We investigated the plasma neurofilament light (NfL) chain levels as potential biomarkers of sarcopenia in AD patients. DESIGN SETTING, PARTICIPANTS, MEASUREMENTS: We conducted a cross-sectional, observational study on older adults, including controls and patients with AD (n = 38-44/group). We measured the frequency of sarcopenia, body composition, handgrip strength (HGS), gait speed, and short physical performance battery (SPPB) in the study participants. We also measured the plasma NfL levels as marker of neurodegeneration. RESULTS: AD was associated with a higher frequency of sarcopenia and reduced HGS, gait speed, and SPPB scores (all p < 0.05). The higher plasma NfL levels in AD patients were correlated with lower HGS, gait speed, and SPPB scores (all p < 0.05). Plasma NfL exhibited moderate accuracy in diagnosing sarcopenia (area under the curve; AUC = 0.701, p < 0.001) and functional dependency (AUC = 0.772, p < 0.001). Among different subgroups of AD, moderate AD was associated with more advanced sarcopenia and functional dependency than early and mild AD. Patients with AD also exhibited heightened inflammation and oxidative stress. CONCLUSION: Altogether, plasma NfL may be a preliminary tool in diagnosing advanced sarcopenia and functional dependency in AD. The study is relevant to non-ambulant and/or comatose AD patients with sarcopenia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Basic Medical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates. rqaisar@sharjah.ac.ae.
- Space Medicine Research Group, Research Institute of Medical and Health Science, University of Sharjah, Sharjah, 27272, United Arab Emirates. rqaisar@sharjah.ac.ae.
- Cardiovascular Research Group, Research Institute of Medical and Health Science, University of Sharjah, Sharjah, 27272, United Arab Emirates. rqaisar@sharjah.ac.ae.
- Department of Basic Medical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.
- Iron Biology Research Group, Research Institute of Medical and Health Science, University of Sharjah, Sharjah, 27272, United Arab Emirates.
- Department of Neurology and Stroke Medicine, Rehman Medical Institute, Peshawar, 25124, Pakistan.
Förderung
- University of Sharjah
Zitieren
APA
Qaisar, R., Karim, A., Iqbal, M. S., Alkahtani, S. A., & Ahmad, F. (2025). Associations of plasma Neurofilament light chain with sarcopenia and physical capacity in patients with Alzheimer’s diseases. Acta Neurologica Belgica. https://doi.org/10.1007/s13760-025-02759-2
Vancouver
Qaisar R, Karim A, Iqbal MS, Alkahtani SA, Ahmad F. Associations of plasma Neurofilament light chain with sarcopenia and physical capacity in patients with Alzheimer’s diseases. Acta Neurologica Belgica. 2025. doi:10.1007/s13760-025-02759-2
BibTeX
@article{Qaisar2025,
author = {Qaisar, Rizwan and Karim, Asima and Iqbal, M Shahid and Alkahtani, Shaea A and Ahmad, Firdos},
title = {Associations of plasma Neurofilament light chain with sarcopenia and physical capacity in patients with Alzheimer’s diseases},
journal = {Acta Neurologica Belgica},
year = {2025},
doi = {10.1007/s13760-025-02759-2}
}
EUVIMED